
Glimiwun M 2mg/500mg Tablet
Marketer
Wunderz Pharmaceuticals
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glimiwun M 2mg/500mg Tablet
Diabetol Duo 2mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are crucial for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before using this medication if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Uses of Glimiwun M 2mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Glimiwun M 2mg/500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimiwun M 2mg/500mg Tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.
Common Side effects of Glimiwun M 2mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimiwun M 2mg/500mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 2mg/500mg Glimiwun M tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
How Glimiwun M 2mg/500mg Tablet works:
Glimiwun M 2mg/500mg tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's response to insulin.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimiwun M 2mg/500mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimiwun M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Administering Glimiwun M 2mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimiwun M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimiwun M 2mg/500mg tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, a low initial dose is typically recommended; however, the medication is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimiwun M 2mg/500mg Tablet :
Should you forget a Glimiwun M 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimiwun M 2mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
